How are DNA Stoffwechseltest and blood sugar related?

DNA metabolism tests (e.g., MyBody-X) analyze variants like TCF7L2, which are associated with type 2 diabetes risk. However, the link to blood sugar is weak: individual variant effect sizes are small, and personalized dietary advice based solely on these genes is not clinically validated. Studies show TCF7L2 variants affect insulin secretion, but their impact on fasting or postprandial glucose is modest and overshadowed by lifestyle factors. Professional organizations advise against using such tests for diet planning, as evidence comes mostly from GWAS associations, not randomized controlled trials. Continuous glucose monitoring (CGM) or medical guidance is more reliable. Caveat: These tests are not intended for children or medical diagnosis. Genetic information may encourage healthier habits but does not replace evidence-based blood sugar management.